Stereotaxis has won FDA approval for the MAGiC Magnetic Interventional Ablation Catheter. The device is a robotically ...

Milestone Pharmaceuticals ( ($MIST) ) has issued an announcement. On January 6, 2026, Milestone Pharmaceuticals announced that the European ...

European decision on approval is expected by Q1 2027If approved, etripamil nasal spray is expected to offer patients a safe and effective ...

Milestone Pharmaceuticals (MIST) announced the acceptance of a Marketing Authorization Application, MAA, by the European Medicines Agency, EMA, ...

Ablation of supraventricular tachycardia in elderly persons presents a challenging problem to electrophysiologists. Friable cardiac structures, prone to catheter perforation, comorbid cardiovascular ...

NF was a 24-year-old gravida 5 Para 1031 African-American woman presented for a prenatal visit at 38 weeks of gestation. As part of her visit, the fetal heart rate was auscultated and found to be ...

I'm lying on my back with my legs in the air and thumb in my mouth, blowing out hard. But it's not working. My heart is still going a million miles an hour. I'd experienced episodes of rapid heartbeat ...

Supraventricular tachycardia is a term used to describe any heart rhythm that is greater than 100 beats per minute originating from above the AV node (the atrium). The term “SVT” can be confusing at ...

Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.

FDA approval of MAGiC is a significant milestone for Stereotaxis and the community of physicians pioneering robotics in electrophysiology. It ensures the benefits of Robotic Magnetic Navigation can ...